🔎 Trials Near Me

Dachaigh › Cancer briste triple-negative › California › Mountain View

Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an Mountain View, CA

Tha 8 sgrùdaidhean airson Cancer briste triple-negative a’ lorg phàirtichean aig làraichean ann agus timcheall air Mountain View (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

A’ fastadhSgrùdadh amharc
  • Stanford University, Palo Alto · 5 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04981119

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

A’ fastadhÌre 3
  • El Camino Hospital Cancer Center ( Site 0096), Mountain View
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06966700

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

A’ fastadhÌre 2
  • Stanford University, Stanford · 5 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT04768426

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

A’ fastadhÌre 2/3
  • Local Institution - 0358, Stanford · 5 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06926868

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

A’ fastadhÌre 1
  • Stanford University Medical Center, Palo Alto · 5 mìle air falbh
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06562192

A Study of LY4175408 in Participants With Advanced Cancer

A’ fastadhÌre 1
  • Stanford Medicine Cancer Center, Stanford · 5 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07046923

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

A’ fastadhÌre 1/2
  • Stanford Women's Cancer Center, Palo Alto · 5 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT04300556

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

A’ fastadhÌre 1
  • Stanford University, Stanford · 5 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Gearr 2024 · NCT04282044

Sgrùdaidhean Cancer briste triple-negative ann am bailtean eile

Sgrùdaidhean eile ann an Mountain View

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.